The firm will use machine learning and bioinformatics, and will generate new genomic data to help improve and personalize treatment of BRCA mutation carriers.
The University of Edinburgh analyzed more than 6,000 genomes in a year, an effort made possible by a computing center dubbed a "genome factory" by its director.
The funding will support expansion of the firm's genetics-related literature analysis tool, Mastermind.
The companies are bundling their software and hardware with the goal of accelerating "DNA-to-diagnosis" time in clinical settings
The consortium is collecting data from different omics streams for a cohort of individuals with autism spectrum disorders with the long-term goal of improving treatment.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.